# A Study of LY3526318 in Healthy Women

> **NCT04183283** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 16 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY3526318
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04183283
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-12
- **Primary completion:** 2020-02-28
- **Final completion:** 2020-03-06
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04183283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04183283, "A Study of LY3526318 in Healthy Women". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04183283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*